drugset / Trial / NCT06419075

Tranexamic Acid in Vaginal Reconstructive Surgery

NCT06419075

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Tranexamic acid (TXA) has been demonstrated to reduce blood loss in trauma, orthopedic, cardiac, and plastic surgeries in numerous well-designed and adequately powered studies. As a result of this evidence for benefit, TXA is routinely used to reduce blood loss during these surgeries. There are no studies regarding the use of TXA in urogynecology. The investigators seek to explore the effect and safety of local infiltration of TXA in vaginal reconstructive surgery.

Timeline

Start
2024-07-01
Primary completion
2025-01-27
Completion
2025-01-27

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 100 mg Other
Subject Vasopressin Peptide 5 iu Other

Indications